Effects of Persistent Innate Immune Activation on Vaccine Efficacy

NCT02429583 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped Unable to enroll sufficient subjects

Conditions

Hepatitis C Infection

Interventions

DRUG: Recombivax

Sponsor

Rockefeller University

Collaborators

[object Object]